Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- Cleerly, Inc.
- Study ID
- NCT04279496
- Status
- Enrolling By Invitation
Conditions
- Coronary Artery Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.
Key Dates
- Start date
- Jun 1, 2020
- Status verified
- Jun 2026
- Primary completion
- Jun 1, 2027
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 15,000 participants (estimated)
Primary Outcome Measure
Coronary CT Angiography EvaluatioN For Clinical Outcomes [ Time Frame: June 2020- June 2022 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22904 | - |
Find similar trials in Charlottesville, VA
By research site
Related Studies
- Product Surveillance RegistryRecruiting · Medtronic · Birmingham, Alabama
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic StentingEnrolling By Invitation · Philips Clinical & Medical Affairs Global · Birmingham, Alabama
- RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)PHASE3 · Recruiting · MedTrace Pharma A/S · Iowa City, Iowa
- Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel DiseaseRecruiting · Population Health Research Institute · Los Angeles, California